TLS Advisors LLC

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 12, 2024), TLS Advisors LLC reported 19 stock positions worth $47.3 million. Its top holding was BHP Group Ltd.-Spon ADR (BHP) at 20.5% of the portfolio, followed by Rio Tinto PLC-Spon ADR (RIO, 15.5%) and Eqt (EQT, 15.3%). Compared with Q2 2024, it opened 1 new position, sold out of 1, added to 4 and reduced 2. The biggest buy was BHP Group Ltd.-Spon ADR (BHP, shares +26%) and the biggest sale Xoma Royalty (XOMA, shares −1%).

Most Recent 13F
Q2 2026
Location
MIAMI, FL
CIK
0001768824
Portfolio Value
$47.3M (Q3 2024)
SEC Filing
0001642044-24-000014 ↗ filed Nov 12, 2024

Holdings Value

0$10.0M$20.0M$30.0M$40.0M$50.0M Q1 2024: $43.0M Q1 2024 Q2 2024: $40.0M Q2 2024 Q3 2024: $47.3M $47.3M Q3 2024 Q4 2024: $43.7M Q4 2024 Q1 2025: $44.3M Q1 2025 Q2 2025: $32.0M Q2 2025 Q3 2025: $34.4M Q3 2025 Q4 2025: $31.1M Q4 2025 Q1 2026: $42.1M Q1 2026 Q2 2026: $34.0M Q2 2026

Holdings 19 stocks · $47.3M
BHP BHP Group Ltd.-Spon ADR 20.47% 155,960 $9.7M Add +25.8%
RIO Rio Tinto PLC-Spon ADR 15.50% 103,100 $7.3M No change
EQT Eqt Corp. 15.34% 198,200 $7.3M Add +31.4%
META Meta Platforms Inc. Class A 12.81% 10,589 $6.1M No change
VALE Vale SA-SP ADR 12.19% 494,000 $5.8M Add +22.3%
XOMA Xoma Royalty Corporation 6.70% 119,744 $3.2M Reduce -0.5%
RRC Range Resources Corp. 3.11% 47,923 $1.5M No change
XENE Xenon Pharmaceuticals Inc. 2.74% 32,956 $1.3M No change
NUE Nucor Corp. 2.54% 8,000 $1.2M No change
OABI Omniab Inc. 2.24% 250,185 $1.1M No change
OVID Ovid Therapeutics Inc. 1.92% 771,531 $910K Reduce -31.4%
HOV Hovnanian Enterprises-A 1.67% 3,872 $791K No change
WY Weyerhaeuser Co. 1.07% 15,000 $508K No change
EWS iShares MSCI Singapore ETF 0.64% 13,600 $301K No change
REGN Regeneron Pharmaceuticals 0.57% 259 $272K Add +3.6%
XLB SS Materials Select Sector 0.43% 2,100 $203K New
ENZB Enzo Biochem Inc. 0.03% 13,616 $15K No change
RVP Retractable Technologies Inc. 0.02% 12,152 $9K No change
NBIS Nebius Group NV 0.00% 17,811 $0 No change

Portfolio Sells Q2 2024 → Q3 2024
XOMA Xoma Royalty Corporation Reduce -0.5% 6.70% −0.44
OVID Ovid Therapeutics Inc. Reduce -31.4% 1.92% −0.25
AEI Alset Inc. Sold out 0.00% −0.05

Portfolio Buys Q2 2024 → Q3 2024
BHP BHP Group Ltd.-Spon ADR Add +25.8% 20.47% +2.75
EQT Eqt Corp. Add +31.4% 15.34% +1.39
VALE Vale SA-SP ADR Add +22.3% 12.19% +0.89
XLB SS Materials Select Sector New 0.43% +0.43
REGN Regeneron Pharmaceuticals Add +3.6% 0.57% −0.08

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 17$34.0MEQT, META, RIO, PICK, FISV
Q1 2026 16$42.1MEQT, RIO, META, PICK, XOMA
Q4 2025 16$31.1MXLP, RIO, PICK, EQT, SPLV
Q3 2025 19$34.4MEQT, META, RIO, PICK, XOMA
Q2 2025 13$32.0MEQT, META, RIO, PICK, XOMA
Q1 2025 15$44.3MEQT, PICK, RIO, META, VALE
Q4 2024Amended 17$43.7MBHP, EQT, META, RIO, VALE
Q3 2024 19$47.3MBHP, RIO, EQT, META, VALE
Q2 2024 19$40.0MBHP, RIO, EQT, META, VALE
Q1 2024 15$43.0MRIO, BHP, EQT, META, VALE